MoneyWorks4Me

Hester Biosciences informs about earnings conference call

23 Jan 2025 Evaluate

Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has scheduled investor interaction through a teleconference call on Thursday, 30 January 2025 at 2:00 pm (IST), post the announcement of financial results for the quarter and nine months period ended 31 December 2024. Details for joining the call are attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1850.20
Dr. Reddys Labs. 1210.65
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1162.00
View more..